首页 | 本学科首页   官方微博 | 高级检索  
检索        

前列腺癌VEGF与MMP-2表达和微血管密度的临床病理关系
引用本文:吴健,张昶.前列腺癌VEGF与MMP-2表达和微血管密度的临床病理关系[J].现代医药卫生,2009(21):3203-3204.
作者姓名:吴健  张昶
作者单位:南京医科大学附属淮安第一医院病理科,江苏淮安223300
摘    要:目的:探讨血管内皮细胞生长因子(VEGF)、基质金属蛋白酶-2(MMP-2)和微血管密度(MVD)与前列腺癌的相关性。方法:应用免疫组织化学方法检测48例前列腺癌组织和20例前列腺增生组织VEGF和MMP-2蛋白的表达并计数微血管密度。结果:前列腺癌组织OVEGF、MMP-2的阳性表达率和MVD值显著高于前列腺增生组织(P〈0.01),VEGF、MMP-2的阳性表达率和MVD值与前列腺癌TNM分期和骨转移情况具有相关性(P〈0.05),前列腺癌VEGF、MMP-2的阳性表达率和MVD值呈正相关(P〈O.01)。结论:VEGF、MMP-2的高表达和MVD增高在前列腺癌发生发展中具有重要作用,检测VEGF、MMP-2和MVD对判断前列腺癌的预后具有重要意义。

关 键 词:前列腺癌  免疫组化  血管内皮细胞生长因子  基质金属蛋白酶-2  微血管密度

Expression of VEGF,NLMP-2 and MVD in prostatic cancer and its relation to clinicopathology
WU Jian,ZHANG Chang.Expression of VEGF,NLMP-2 and MVD in prostatic cancer and its relation to clinicopathology[J].Modern Medicine Health,2009(21):3203-3204.
Authors:WU Jian  ZHANG Chang
Institution:(Department of Pathology,Affiliated Huaian First Hospital of Nanjing Medical University,Huaian,Jiangsu 223300,China)
Abstract:Objective :To explore the expression of VEGF, MMP-2 and MVD in prostatic cancer. Methods:Immunohistochemistry was employed to measure the expression of VEGF, MMP-2 and MVD in 48 cases of prostatic cancer and 20 cases of benign prostatic hyperplasia.Results:The positive expressions of VEGF, MMP-2 and MVD between prostatic cancer and benign prostatic hyperplasia were significantly different (P〈0.01).The positive expressions of VEGF, MMP-2 and MVD were related with the clinical stage and metastasis of prostatic cancer (P〈0.05).The expression of VEGF, MMP-2 and MVD were positively correlated with prostatic cancer(P〈0.01). Conclusion:The expressions of VEGF, MMP-2 and MVD are related with the occurrence and progression of prostatic cancer.
Keywords:Prostatic cancer  Immunohistochemistry  VEGF  MMP-2  MVD
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号